Carisoprodol Tablet
Product Images NDC 71335-1203

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 71335-1203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351203)

Label for Carisoprodol 350 mg tablet, a human prescription drug labeled as a Schedule IV (CIV) controlled substance. The label shows packaging by Bryant Ranch Prepack, including storage instructions at room temperature 20°-25°C (68°-77°F), and warnings to keep drugs out of reach of children and noting possible drowsiness. It references comparison to Soma 350 mg tablets by ScieGen Pharmaceuticals Inc., with the NDC 71335-1203.*

FDA Label Image

Structural Formula Of Carisoprodol (Structure)

Chemical structure of carisoprodol, showing its molecular connectivity with labeled functional groups, as depicted in the product data for CARISOPRODOL 350 mg tablets by Bryant Ranch Prepack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.